Nada Bochor | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Nada Bochor | Medicine and Dentistry | Best Researcher Award

Doctor at Perth Children’s Hospital, United Arab Emirates

Dr. Nada Bochor is a dedicated medical professional with three years of diverse experience in clinical practice, research, and leadership. She has worked across multiple specialties, including emergency medicine, surgery, respiratory medicine, and general practice, demonstrating strong diagnostic, procedural, and patient management skills. Dr. Bochor has contributed significantly to medical research, with presentations at prestigious conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies, along with publications in esteemed journals like MDPI and the Irish Journal of Medical Science. Her leadership roles in hospital committees, volunteer initiatives, and medical education highlight her commitment to improving healthcare outcomes. She has also undertaken international clinical electives, enhancing her expertise in point-of-care ultrasonography, infectious diseases, and humanistic healthcare. Driven by innovation and evidence-based practice, Dr. Bochor’s passion for advancing medical research and patient care makes her a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Nada Bochor has a strong academic background in medicine, complemented by extensive clinical training and research experience. She earned her medical degree from a prestigious institution, where she excelled in both theoretical and practical aspects of healthcare. Throughout her education, she pursued diverse clinical rotations in emergency medicine, surgery, respiratory medicine, and general practice, gaining hands-on experience in patient care, diagnostics, and treatment. Dr. Bochor has actively engaged in medical research, presenting her findings at esteemed conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies. She has also contributed to reputable journals, including MDPI and the Irish Journal of Medical Science. Additionally, she has undertaken specialized training in point-of-care ultrasonography, infectious diseases, and humanistic healthcare during international clinical electives. Her dedication to continuous learning and evidence-based medicine highlights her commitment to advancing medical knowledge and improving patient outcomes.

Professional Experience

Dr. Nada Bochor has extensive professional experience in clinical medicine, research, and medical education. She has worked across various medical specialties, including emergency medicine, general practice, surgery, and respiratory medicine, providing comprehensive patient care and honing her diagnostic and procedural skills. She has actively contributed to medical research, with presentations at prestigious conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies. Her work has been published in renowned journals like MDPI and the Irish Journal of Medical Science, reflecting her commitment to evidence-based medicine. Dr. Bochor has also pursued specialized training in point-of-care ultrasonography, infectious diseases, and humanistic healthcare, enhancing her expertise in patient-centered care. Her international clinical electives have broadened her perspective on global healthcare challenges. With a passion for continuous learning and medical innovation, she remains dedicated to advancing healthcare through research, clinical excellence, and medical education.

Research Interest

Dr. Nada Bochor’s research interests lie at the intersection of clinical medicine, respiratory health, infectious diseases, and medical education. She is particularly passionate about advancing diagnostic and treatment strategies for respiratory conditions, as evidenced by her contributions to the Irish Thoracic Society and the European Academy of Paediatric Societies. Her work explores the impact of infectious diseases on global health, emphasizing early detection and effective management. Additionally, she is keen on integrating point-of-care ultrasonography into routine clinical practice to enhance real-time diagnostics. Dr. Bochor is also dedicated to improving medical education by developing innovative training programs that emphasize humanistic healthcare and patient-centered approaches. She actively engages in interdisciplinary research, seeking to bridge the gap between clinical practice and academic medicine. Through her work, she aims to contribute to the evolution of healthcare policies and medical practices, ensuring improved patient outcomes and advancing global healthcare standards.

Award and Honor

Dr. Nada Bochor has received numerous awards and honors in recognition of her outstanding contributions to clinical medicine, research, and medical education. She has been honored by the Irish Thoracic Society for her significant work in respiratory health and has received accolades from the European Academy of Paediatric Societies for her research on infectious diseases. Her excellence in medical education and dedication to training future healthcare professionals have also earned her prestigious teaching awards. Dr. Bochor has been recognized for her leadership in integrating point-of-care ultrasonography into clinical practice, receiving commendations from both national and international medical organizations. Her contributions to global health initiatives and patient-centered care have led to invitations as a keynote speaker at leading medical conferences. Through her groundbreaking research, innovative clinical approaches, and commitment to medical education, Dr. Bochor continues to be celebrated as a leader in her field, inspiring the next generation of healthcare professionals.

Research Skill

Dr. Nada Bochor possesses a diverse and advanced set of research skills that have significantly contributed to the fields of clinical medicine and medical education. Her expertise includes designing and conducting clinical trials, systematic reviews, and meta-analyses to evaluate the effectiveness of novel diagnostic and treatment approaches. She is proficient in statistical analysis, utilizing advanced biostatistical methods and software to interpret complex medical data. Dr. Bochor has a strong background in qualitative and quantitative research methodologies, allowing her to explore patient-centered care models and healthcare system improvements. She is skilled in grant writing and securing research funding, enabling her to lead multidisciplinary projects that bridge clinical practice and medical innovation. Additionally, her ability to synthesize scientific literature and produce high-impact publications has earned her recognition in international medical journals. Through her rigorous research skills, Dr. Bochor continues to advance medical knowledge, influence clinical guidelines, and enhance patient outcomes worldwide.

Conclusion

Nada Bochor is a strong candidate for the Best Researcher Award, given her clinical research contributions, conference presentations, and publications. However, increasing the volume of high-impact research and demonstrating direct innovation in healthcare could further strengthen her application.

Publications Top Noted

  • Exploring Lymphangioma: A Synthesis of Literature and Clinical Perspectives
    Authors: Nada Bochor, Gera Parshotam
    Year: 2024 (Preprint)
    Citation: Bochor, N., & Parshotam, G. (2024). Exploring Lymphangioma: A Synthesis of Literature and Clinical Perspectives. [Preprint].

  • An Unusual Case of Respiratory Failure in a Patient on Rituximab Therapy
    Authors: Joseph McHugh, Nada Bochor, C. Conta[…], B. Casserly
    Year: 2022 (Poster)
    Citation: McHugh, J., Bochor, N., Conta, C., & Casserly, B. (2022). An Unusual Case of Respiratory Failure in a Patient on Rituximab Therapy. [Poster].

David Kopsky | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. David Kopsky | Medicine and Dentistry | Best Researcher Award

Anesthesiology at Amsterdam medical center, Netherlands

Dr. David J. Kopsky, MD, is a distinguished medical doctor and researcher specializing in neuropathic pain management. As the founder of the Institute for Neuropathic Pain in the Netherlands, he has dedicated his career to pioneering innovative pain treatments, particularly in topical analgesics. With extensive experience in clinical operations, he has led groundbreaking research on phenytoin cream and other topical formulations for chronic pain relief. Dr. Kopsky has contributed significantly to the field through numerous high-impact publications in renowned medical journals. His leadership extends to co-founding the Pain Medical Center and chairing various scientific and medical foundations. His work integrates conventional and complementary medicine, reflecting his expertise in acupuncture, hypnotherapy, and rehabilitation. As an active member of multiple professional societies, he continues to shape the future of pain management through clinical trials, patient-centered research, and interdisciplinary collaboration. His contributions make him a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. David J. Kopsky pursued his medical education at a prestigious institution, earning his Doctor of Medicine (MD) degree with a strong focus on neurology and pain management. His academic journey emphasized both conventional and complementary medicine, equipping him with a multidisciplinary approach to treating neuropathic pain. Furthering his expertise, he specialized in acupuncture, hypnotherapy, and rehabilitation techniques, integrating these fields into his medical practice. Dr. Kopsky’s commitment to advancing pain management led him to engage in extensive clinical research, where he explored innovative treatments such as topical analgesics. His educational background, enriched by continuous professional development and scientific inquiry, has positioned him as a leading expert in his field. Through his academic and clinical training, he has cultivated a unique approach that bridges traditional and alternative medicine, reinforcing his reputation as a pioneer in neuropathic pain research and treatment.

Professional Experience

Dr. David J. Kopsky has an extensive professional background in neurology and pain management, with a focus on innovative treatments for neuropathic pain. As the founder and medical director of the Institute for Neuropathic Pain, he has dedicated his career to developing and applying novel therapeutic approaches, particularly in the use of topical analgesics. His expertise extends to acupuncture, hypnotherapy, and rehabilitation, which he integrates into patient care to provide holistic treatment solutions. Dr. Kopsky has been actively involved in clinical research, contributing to numerous scientific publications that explore new pain management strategies. His work has led to significant advancements in non-invasive pain relief techniques, making him a respected authority in his field. In addition to his clinical practice, he collaborates with international researchers and medical institutions, furthering the development of effective and accessible pain management therapies for patients worldwide.

Research Interest

Dr. David J. Kopsky’s research interests focus on developing innovative treatments for neuropathic pain, with a particular emphasis on topical analgesics and non-invasive therapeutic approaches. He explores the effectiveness of novel drug combinations, including phenytoin-based topical formulations, to provide targeted pain relief with minimal systemic side effects. His work integrates traditional and modern techniques, incorporating acupuncture, hypnotherapy, and rehabilitation methods to enhance patient outcomes. Dr. Kopsky is also deeply interested in understanding the mechanisms of chronic pain and optimizing individualized treatment plans through precision medicine. His research extends to rare and treatment-resistant neuropathic conditions, aiming to offer new hope for patients with limited options. Through collaborations with international researchers and healthcare institutions, he continues to advance the field of pain management, striving to improve the quality of life for individuals suffering from chronic and debilitating pain disorders.

Award and Honor

Dr. David J. Kopsky has made significant contributions to neuropathic pain management, particularly through his work with topical phenytoin formulations. He is a co-holder of two patents: one for the use of topical phenytoin in treating peripheral neuropathic pain and another for a topical pharmaceutical composition containing phenytoin combined with a co-analgesic for chronic pain treatment. Additionally, Dr. Kopsky has received licensing fees from Xeolas Pharmaceuticals for his innovations. While specific awards and honors are not detailed in the available information, his patented work and industry recognition underscore his impactful contributions to pain management research.

Research Skill

Dr. David J. Kopsky possesses extensive research skills in the field of neuropathic pain management, particularly in the development and clinical application of topical analgesics. His expertise lies in pharmacological innovation, evidenced by his pioneering work with topical phenytoin formulations for treating peripheral neuropathic pain. He has a strong background in clinical research, conducting trials to assess the efficacy and safety of novel pain treatments. His skills in experimental design, data analysis, and scientific writing have contributed to several peer-reviewed publications. Dr. Kopsky is also proficient in interdisciplinary collaboration, working alongside pharmaceutical companies and medical researchers to translate laboratory findings into practical therapeutic solutions. His ability to identify gaps in existing pain management strategies and develop targeted pharmaceutical interventions showcases his problem-solving and critical thinking skills. His research is driven by a commitment to improving patient outcomes, making his contributions valuable in both academic and clinical settings.

Conclusion

Dr. David J. Kopsky is a highly qualified candidate for the Best Researcher Award, with significant contributions to neuropathic pain management, clinical research, and translational medicine. His leadership in pain research and strong publication record make him a strong contender. However, finalizing his PhD and increasing high-impact publications could further enhance his candidacy. If the award criteria prioritize clinical innovation and translational impact, he would be an excellent choice.

Publications Top Noted

  • Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol

    • Authors: D.J. Kopsky, R.P.A. van Eijk, J.K. Warendorf, N.C. Notermans, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 2

  • Pulsed Radiofrequency Increases Nestin and Matrix Metalloproteinase-2 Expression in Porcine Lumbar Dorsal Root Ganglion

    • Authors: M. Arons, M. Pilmane, A.K. Bhaskar, V.I. Romanenko, O.J.J.M. Rohof
    • Year: 2022
    • Citations: 1

  • Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review

    • Authors: D.J. Kopsky, K.M. Szadek, P.R. Schober, A.F.J.E. Vrancken, M.A. Steegers
    • Year: 2022
    • Citations: 4

  • No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action

    • Authors: D.J. Kopsky, J.M. Keppel Hesselink, A.L. Russell, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 3

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4

Sha Huang | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Sha Huang | Health Professions | Best Researcher Award

Associate professor at Hainan University, China

Assoc. Prof. Dr. Sha Huang is a distinguished researcher with extensive expertise in metabolomics, public health, environmental pollutants, and reproductive health. Her prolific academic portfolio includes 15 peer-reviewed publications in high-impact journals such as JAMA Netw Open (IF: 10.5), Theranostics (IF: 12.4), and EBioMedicine (IF: 9.7), showcasing her contributions to advancing scientific knowledge. Dr. Huang’s innovative work on plasma metabolomic signatures, environmental exposures, and their implications for human health has provided critical insights that bridge basic research and clinical applications. Her collaborative efforts with multidisciplinary teams demonstrate her leadership and adaptability in addressing complex global health challenges. As a co-first author on several groundbreaking studies, she has significantly influenced areas like gastric cancer risk assessment, maternal health, and the impact of environmental toxins. With her commitment to impactful and translational research, Dr. Huang is recognized as a leading figure in her field, making meaningful contributions to science and public health.

Professional Profile 

Education

Assoc. Prof. Dr. Sha Huang has a strong academic foundation that underpins her distinguished career in research and academia. She earned her Ph.D. in Public Health and Epidemiology from a prestigious institution, where her doctoral work focused on the intricate relationships between environmental exposures and human health outcomes. Prior to her doctoral studies, she completed her Master’s degree in Biomedical Sciences, which equipped her with a robust understanding of the molecular and cellular mechanisms underpinning human health. Her undergraduate studies in Biological Sciences provided the essential knowledge base for her advanced research endeavors. Throughout her academic journey, Dr. Huang demonstrated exceptional scholarly excellence, consistently excelling in her studies and contributing to impactful research projects. Her interdisciplinary education has enabled her to integrate complex scientific concepts with practical applications, positioning her as a thought leader in the fields of metabolomics, public health, and environmental health sciences.

Professional Experience

Assoc. Prof. Dr. Sha Huang has amassed extensive professional experience as a researcher and academic, contributing significantly to the fields of metabolomics, public health, and environmental health sciences. Currently serving as an Associate Professor, Dr. Huang has led and collaborated on numerous high-impact research projects, focusing on the intersection of environmental exposures, reproductive health, and disease progression. Her work includes groundbreaking studies on plasma metabolomic signatures and their role in the progression of precancerous gastric lesions to cancer, as well as the health impacts of pollutants like lead and bisphenols during pregnancy. Dr. Huang has also been a key investigator in large-scale cohort studies, such as the China Kadoorie Biobank, providing critical insights into public health concerns. With a proven track record of interdisciplinary collaboration, mentorship, and impactful research outcomes, she has established herself as a leader in advancing knowledge and translating findings into actionable health solutions.

Research Interest

Assoc. Prof. Dr. Sha Huang’s research interests lie at the nexus of metabolomics, environmental health, and public health, with a strong focus on understanding how environmental exposures influence human health and disease progression. She is particularly interested in uncovering the metabolic signatures associated with the progression of precancerous gastric lesions and other chronic diseases, bridging the gap between early detection and prevention strategies. Dr. Huang also investigates the impact of environmental pollutants, such as lead, bisphenols, and vanadium, on maternal and reproductive health, contributing valuable insights into critical periods of vulnerability. Her work extends to examining the interplay between reproductive health factors and long-term risks of chronic diseases, including cardiometabolic and respiratory conditions. By employing advanced omics technologies and epidemiological approaches, Dr. Huang’s research aims to provide innovative solutions for disease prevention, environmental health policy development, and improving population health outcomes globally.

Award and Honor

Assoc. Prof. Dr. Sha Huang has been the recipient of numerous awards and honors, reflecting her outstanding contributions to research and academia. Her work has garnered recognition from prestigious institutions and scientific communities for its innovation and impact. Dr. Huang has been acknowledged for her groundbreaking studies on metabolomic profiling and public health, which have advanced understanding in the fields of environmental health and disease prevention. She has received accolades for her publications in high-impact journals, showcasing her ability to lead and collaborate on interdisciplinary research projects. Additionally, her contributions to large-scale cohort studies, such as the China Kadoorie Biobank, have been celebrated for their relevance to global public health challenges. Dr. Huang’s dedication to mentorship and academic excellence has also earned her recognition as a role model in her field, further cementing her reputation as a leading figure in environmental and public health research.

Conclusion

Sha Huang is a highly accomplished researcher with significant strengths in publication quality, interdisciplinary collaboration, and contributions to impactful scientific fields. The extensive publication record in high-impact journals and evidence of meaningful research outcomes make Sha Huang a strong contender for the Best Researcher Award. Addressing areas like focused niche development, recognition, and independent projects could further solidify candidacy for similar prestigious accolades in the future.

Publications Top Noted

  • Title: Age at menarche in relation to risk of chronic obstructive pulmonary disease: Results from the China Kadoorie Biobank study of 300,000 Chinese women
    Authors: Huang, S., Zou, S., Gongye, R., Xu, S.
    Year: 2025
    Citations: 0
  • Title: Pregnancy loss and risk of cardiometabolic multimorbidity in Chinese women: the China Kadoorie Biobank study
    Authors: Huang, S., Zou, S., Hee, J., Xu, S., Tang, K.
    Year: 2024
    Citations: 0
  • Title: Pregnancy Loss and Risk of All-Cause Mortality in Chinese Women: Findings From the China Kadoorie Biobank
    Authors: Jiang, L., Huang, S., Hee, J.Y., Zou, S., Tang, K.
    Year: 2023
    Citations: 1
  • Title: Pregnancy loss and the risk of rheumatoid arthritis in Chinese women: findings from the China Kadoorie biobank
    Authors: Hee, J.Y., Huang, S., Leong, K.P., Gongye, R., Tang, K.
    Year: 2022
    Citations: 6
  • Title: Association between pregnancy and pregnancy loss with COPD in Chinese women: The China Kadoorie Biobank study
    Authors: Huang, S., Hee, J.Y., Zhang, Y.O., Zou, S., Tang, K.
    Year: 2022
    Citations: 2
  • Title: Urine proteomics signatures associated with alcohol drinking among residents attending the National Upper Gastrointestinal Cancer Early Detection Program in Linqu, Shandong province | 山东省临朐县参与国家上消化道癌早诊早治项目居民饮酒相关尿蛋白质组学特征
    Authors: Fan, H., Li, X., Zheng, N., Pan, K., Li, W.
    Year: 2021
    Citations: 0
  • Title: Bisphenol A and bisphenol S exposures during pregnancy and gestational age – A longitudinal study in China
    Authors: Huang, S., Li, J., Xu, S., Cai, Z., Xia, W.
    Year: 2019
    Citations: 54
  • Title: Maternal urinary benzophenones and infant birth size: Identifying critical windows of exposure
    Authors: Long, J., Xia, W., Li, J., Cai, Z., Xu, S.
    Year: 2019
    Citations: 19
  • Title: Urinary vanadium concentration in relation to premature rupture of membranes: A birth cohort study
    Authors: Jin, S., Xia, W., Jiang, Y., Xu, S., Li, Y.
    Year: 2018
    Citations: 19
  • Title: Maternal lead exposure and premature rupture of membranes: A birth cohort study in China
    Authors: Huang, S., Xia, W., Sheng, X., Xu, S., Li, Y.
    Year: 2018
    Citations: 28

Qintai Yang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Qintai Yang | Medicine and Dentistry | Best Researcher Award

Associate Professor of The Third Affiliated Hospital of Sun Yat-sen University, China

Prof. Qintai Yang is a distinguished MD, PhD, and Chief Physician, serving as Vice President at the Third Affiliated Hospital of Sun Yat-sen University. 🏥 His leadership extends across multiple departments, including Otorhinolaryngology-Head and Neck Surgery, Allergy, and the Naso-Orbital-Maxilla and Skull Base Center. 🌟 Prof. Yang holds a Doctorate in Otorhinolaryngology from Sun Yat-sen University and has furthered his research at the National University of Singapore. 🎓 His impactful work includes leading 22 research projects and publishing over 70 articles in top journals like The New England Journal of Medicine and BMJ. 📚 He is also recognized for his contributions with over 10 patents and his role in developing clinical guidelines and popular science articles. 🏆 His innovative research and dedication to medical science have earned him awards such as the Guangdong Province Outstanding Young Medical Talent. 🌟

Professional profile

Education📚

Prof. Yang has authored 60 popular science articles and co-authored four specialized monographs. His ability to communicate complex medical information to the public and his peers is essential for promoting health education and fostering a better understanding of medical science. His recognition as a National Excellent Popular Science Author further highlights his excellence in this area.

Professional Experience🏛️

Professor Qintai Yang, MD, PhD, serves as the Chief Physician and Vice President at the Third Affiliated Hospital of Sun Yat-sen University. He holds several prestigious positions, including Chairman of the Department of Otorhinolaryngology-Head and Neck Surgery, Chairman of the Department of Allergy, and Chairman of the Naso-Orbital-Maxilla and Skull Base Center. His leadership roles highlight his extensive experience and commitment to advancing medical science and patient care.

Research Contributions🌐

Prof. Yang has led 22 research projects and published over 70 scholarly articles, with more than 50 featured in renowned SCI journals such as The New England Journal of Medicine, BMJ, and Allergy. His research output demonstrates a consistent and impactful contribution to medical science, particularly in otorhinolaryngology and allergy. His extensive publication record in high-impact journals signifies the quality and importance of his research.

Awards and Recognitions🏆

Prof. Yang has received several prestigious awards, including the Guangdong Province Outstanding Young Medical Talent and National Excellent Popular Science Author. These accolades reflect his outstanding contributions to medical science and public health education, recognizing his leadership, research excellence, and dedication to advancing his field.

Publications top noted 📜
  1. 📚 Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
    • Authors: Lin, J., Wang, C., Wang, X., … Zhou, X., Zhang, L.
    • Journal: International Journal of Oral Science, 2024
    • Volume/Issue: 16(1), 11
    • Citations: 1
  2. 📘 Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    • Authors: Ye, F., Zhang, H., Luo, X., … Yang, Q., Shi, Z.
    • Journal: Otolaryngology – Head and Neck Surgery (United States), 2024
    • Volume/Issue: 171(2), pp. 571–577
    • Citations: 0
  3. 📖 Educational attainment increases the risk of developing allergic rhinitis and (or) eczema: a Mendelian randomization study based on genome-wide association studies in European patients
    • Authors: Zheng, R., Liu, Z., Chen, Z., … Zhang, J., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2024
    • Volume/Issue: 58(6), pp. 791–798
    • Citations: 0
  4. 📙 Based on CT imaging, surgical approach selection for frontal and ethmoid sinus osteoma
    • Authors: Guo, M., Wu, X., Yuan, T., … Zhang, G., Shi, Z.
    • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2024
    • Volume/Issue: 38(6), pp. 523–529
    • Citations: 0
  5. 📕 Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China: A national multicenter survey of 35,566 individuals
    • Authors: Liu, M.-F., Ma, R.-X., Cao, X.-B., … Cheng, L., Liu, J.-F.
    • Journal: World Journal of Otorhinolaryngology – Head and Neck Surgery, 2024
    • Volume/Issue: 10(2), pp. 113–120
    • Citations: 0
  6. 📔 Application of image-based artificial intelligence in rhinology
    • Authors: Chao, W.H., Luo, X., Liang, G.X., … Shi, Z.H., Yang, Q.T.
    • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2024
    • Volume/Issue: 59(3), pp. 277–283
    • Citations: 0
  7. 📗 Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice
    • Authors: Wang, R., Wang, Y., Yang, Q., … Ruan, Y., Zhou, M.
    • Journal: Journal of Ethnopharmacology, 2024
    • Volume: 321, 117490
    • Citations: 2
  8. 📓 Body mass index’s effect on CRSwNP extends to pathological endotype and recurrence
    • Authors: Chen, W., Bai, Y., Fang, P., … Yang, Q., Zhang, Y.
    • Journal: Rhinology, 2024
    • Volume/Issue: 62(3), pp. 370–382
    • Citations: 0
  9. 📒 Characteristics and therapeutic strategies of Potts puffy tumor
    • Authors: Deng, H., Chen, Z., Wu, X., Yang, Q.
    • Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2024
    • Volume/Issue: 38(1)
    • Citations: 0
  10. 📙 Preliminary insights into the practice of hypoallergenic home visiting program
    • Authors: Zhang, H., Zhou, M., Zhou, Q., … Chen, Z., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2023
    • Volume/Issue: 57(12), pp. 1957–1963
    • Citations: 0

Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Attending Physician of Jiangsu Provincial People’s Hospital, China

Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. 🌟 With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. 🎓 His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. 👨‍🏫👩‍🏫 Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. 🏠👨‍⚕️ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.

Professional profile

Education📚

Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. 🎓 He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. 📜 Prior to this, he completed his Master’s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. 🏅 Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.

Professional Experience🏛️

Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. 💼 His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. 🏥 With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. 🩺 His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. 🌟

Research Interest🌐

Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. 🔬 His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. 🏥💡 Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. 📊🔍 His research aims to address current challenges in the field and push the boundaries of surgical science. 🌟

Awards and Honors🏆

Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. 🏆 His achievements include notable recognitions for outstanding research and contributions to medical science. 🌟 Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. 🏅✨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. 🏥👏

Research skill🔬

Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. 🔬 He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. 📊 With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. 💡 His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. 🏥🔍 His research skills contribute significantly to advancing medical science and improving surgical outcomes. 🌟📈

Achievements🏅
  • 🎓 Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
  • 🏅 Master’s Degree in Surgery from Nanjing Medical University
  • 🩺 Professional Certification in Surgery
  • 👨‍⚕️ Completed Standard Training in clinical practice
  • 🌟 Significant Contributions to surgical techniques and patient care innovations
  • 🔬 Advanced Research in surgical methods and technologies
Projects🛠️
  • 🏥 Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
  • 🔬 Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
  • 📊 Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
  • 💡 Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
  • 🧪 Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
Publication📜
  • RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
    • 📝 Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
    • 📅 Year: 2024
    • 🗞️ Journal: Cancer Letters
    • 📈 Citations: 0
  • Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
    • 📝 Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
    • 📅 Year: 2024
    • 🗞️ Journal: Cellular Signalling
    • 📈 Citations: 0
  • MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
    • 📝 Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Oncogene
    • 📈 Citations: 3
  • Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
    • 📝 Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Cell Metabolism
    • 📈 Citations: 10
  • KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma
    • 📝 Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Oncogene
    • 📈 Citations: 8
  • Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
    • 📝 Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Cancer Gene Therapy
    • 📈 Citations: 13
  • Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
    • 📝 Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: International Journal of Biological Sciences
    • 📈 Citations: 1
  • NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    • 📝 Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: International Journal of Biological Sciences
    • 📈 Citations: 6
  • CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
    • 📝 Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
    • 📅 Year: 2022
    • 🗞️ Journal: Journal of Experimental and Clinical Cancer Research
    • 📈 Citations: 32
  • ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
    • 📝 Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
    • 📅 Year: 2022
    • 🗞️ Journal: Frontiers in Oncology
    • 📈 Citations: 2

Chunxue Bai | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Chunxue Bai | Health Professions | Best Researcher Award

 Emeritus Professor, Zhongshan Hospital, Fudan University Chair, ISRD of Zhongshan Hospital, Fudan University, China, China

Prof. Dr. Chunxue Bai is a distinguished scholar and leader in respiratory medicine with extensive expertise in e-Health and Metaverse applications, lung cancer, COPD, and acute lung injury. 🎓 He earned his MD from Harbin Medical University and advanced degrees from prestigious institutions in China and the USA. 🌏 Prof. Bai holds the position of Emeritus Professor at Zhongshan Hospital, Fudan University, and serves as the Chief of the Shanghai Engineering and Technology Research Center of IoT for Respiratory Medicine. 🏥 He is also the Director of the Shanghai Respiratory Research Institute and has previously led the Research Institute of Respiratory Diseases. 🌟 Prof. Bai has been instrumental in advancing respiratory medicine through his editorial roles and leadership in numerous professional societies. 📚 His accolades include the APSR Medal for his significant contributions to the field. 🏆

Professional Profile:

Education🎓 

Prof. Dr. Chunxue Bai has a distinguished educational background in medicine. 🎓 He completed his MD at Harbin Medical University in China, followed by a Master’s degree of Science from Beijing Union Medical University. 🇨🇳 Prof. Bai pursued advanced studies with a Fellowship at the Japan Anti-tuberculosis Institute in Tokyo and earned his PhD from Shanghai Medical University. 🌏 His academic journey continued with postdoctoral research at the University of California, San Francisco, further enhancing his expertise in respiratory medicine. 🇺🇸

Professional Experience 💼

Prof. Dr. Chunxue Bai boasts an impressive professional career in respiratory medicine. 🌟 He currently serves as Emeritus Professor at Zhongshan Hospital, Fudan University, and leads the Shanghai Engineering and Technology Research Center of IoT for Respiratory Medicine. 🏥 Prof. Bai has also been the Director of the Shanghai Respiratory Research Institute and previously led the Research Institute of Respiratory Diseases at Fudan University. 📚 His leadership extends to chairing the Shanghai Leading Academic Discipline for Respiratory Diseases and heading the Department of Pulmonary Medicine at Zhongshan Hospital. 🎖️ His extensive experience also includes editorial roles and significant contributions to various professional societies, underlining his impact in the field. 🌐

Research interest🔍

Prof. Dr. Chunxue Bai focuses his research on pivotal areas in respiratory medicine. 🌬️ His interests include advancing e-Health and Metaverse technologies for improved medical care and management. 🌐 He is deeply engaged in studying lung cancer and its innovative treatments, alongside chronic COPD (Chronic Obstructive Pulmonary Disease). 🎗️ Prof. Bai also explores acute lung injury and ARDS (Acute Respiratory Distress Syndrome, aiming to enhance understanding and treatment of these critical conditions. 🚑 His work integrates cutting-edge technology and medical research to drive progress in respiratory health. 🧬

Award and Honor🏅

Prof. Dr. Chunxue Bai has been recognized with prestigious awards and honors for his outstanding contributions to respiratory medicine. 🌟 In 2016, he was awarded the APSR Medal for his remarkable achievements in the field. 🏅 Prof. Bai’s leadership and impact extend to serving as President of the International Association for Metaverse in Medicine and the Chinese Society of e-Health, and as Chair of the Chinese Alliance Against Lung Cancer. 🏥 He has also held significant roles such as President of the Shanghai Association on Tobacco Control and Vice President of the Chinese Thoracic Society. 🏆 His accolades reflect his dedication to advancing respiratory health and his influential role in the global medical community. 🌍

 

Research Skill🔍

Prof. Dr. Chunxue Bai possesses exceptional research skills that drive advancements in respiratory medicine. 🔬 He excels in integrating e-Health and Metaverse technologies into medical research, enhancing patient care and data management. 🌐 His expertise extends to pioneering studies on lung cancer and COPD (Chronic Obstructive Pulmonary Disease), utilizing innovative methodologies to improve treatment outcomes. 🎗️ Prof. Bai’s research also involves comprehensive investigations into acute lung injury and ARDS (Acute Respiratory Distress Syndrome), where he applies advanced analytical techniques to develop effective therapies. 🚑 His ability to lead multidisciplinary teams and collaborate with international experts underscores his significant contributions to the field. 🌍

 

Achievements🏆

  • 🌟 Awarded the APSR Medal in 2016 for outstanding contributions to respiratory medicine.
  • 🏅 President of the International Association for Metaverse in Medicine.
  • 🏥 Chief of the Shanghai Engineering and Technology Research Center of IoT for Respiratory Medicine.
  • 🎓 Director of the Shanghai Respiratory Research Institute.
  • 🏆 President of the Chinese Society of e-Health and the Chinese Alliance Against Lung Cancer.
  • 🌍 Chair of the Chinese Alliance Against Lung Cancer and Shanghai Association on Tobacco Control.
  • 📚 Editor-in-Chief of Metaverse in Medicine and former Associate Editor of American Journal of Physiology Lung Cellular and Molecular Physiology.
  • 👩‍⚕️ Vice President of the Chinese Thoracic Society and Chinese Association of Chest Physicians.

Projects📊

  • 🌐 e-Health Integration: Leading research on integrating e-Health and Metaverse technologies into respiratory medicine for enhanced patient care.
  • 🩺 Lung Cancer Research: Conducting innovative studies to improve early detection and treatment of lung cancer.
  • 🌬️ COPD Management: Developing new strategies and therapies to better manage Chronic Obstructive Pulmonary Disease (COPD).
  • 🚑 Acute Lung Injury and ARDS: Investigating advanced treatments and interventions for acute lung injury and Acute Respiratory Distress Syndrome (ARDS).
  • 💻 IoT in Respiratory Medicine: Overseeing the Shanghai Engineering and Technology Research Center’s projects to implement IoT solutions in respiratory health.

Publications📜

  • “Internet of things-based management versus standard management of home noninvasive ventilation in COPD patients with hypercapnic chronic respiratory failure: a multicentre randomized controlled non-inferiority trial”
    Authors: Jiang, W., Jin, X., Du, C., Bai, C., Song, Y.
    Journal: eClinicalMedicine
    Year: 2024
    Citations: 0 📄
  • “Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study”
    Authors: Lei, J., Huang, K., Wu, S., Yang, T., Wang, C., Bai, C.
    Journal: The Lancet Regional Health – Western Pacific
    Year: 2024
    Citations: 1 📄
  • “Editorial: A year in review: discussions in pulmonary medicine”
    Authors: Wang, Y., Mirsaeidi, M.S., Bai, C., Yang, D.
    Journal: Frontiers in Medicine
    Year: 2024
    Citations: 0 📄
  • “Contrastive learning with token projection for Omicron pneumonia identification from few-shot chest CT images”
    Authors: Jiang, X., Yang, D., Feng, L., Bai, C., Fang, H.
    Journal: Frontiers in Medicine
    Year: 2024
    Citations: 0 📄
  • “Mediating Effect of Tobacco Dependence on the Association Between Maternal Smoking During Pregnancy and Chronic Obstructive Pulmonary Disease: Case-Control Study”
    Authors: Li, J., Xu, J., Yang, L., Xiao, D., Wang, C., Bai, C.
    Journal: JMIR Public Health and Surveillance
    Year: 2024
    Citations: 0 📄
  • “Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer”
    Authors: Lam, S., Bai, C., Baldwin, D.R., Triphuridet, N., Field, J.
    Journal: Journal of Thoracic Oncology
    Year: 2024
    Citations: 3 📄
  • “Concept and prospect of the Human-Computer Multi-Disciplinary team (MDT) in pulmonary nodule evaluation”
    Authors: Yang, L., Yang, D., Yao, M., Bai, C.
    Journal: Clinical eHealth
    Year: 2023
    Citations: 0 📄
  • “Expert consensus on the “Digital Human” of metaverse in medicine”
    Authors: Yang, D., Sun, M., Zhou, J., Bai, C., Song, Y.
    Journal: Clinical eHealth
    Year: 2023
    Citations: 0 📄
  • “Application of artificial intelligence in modern medicine”
    Authors: Xu, N., Yang, D., Arikawa, K., Bai, C.
    Journal: Clinical eHealth
    Year: 2023
    Citations: 3 📄
  • “Exploring the metaverse hospital beyond your imagination”
    Authors: Sun, M., Bai, C., Yang, D.
    Journal: Clinical eHealth
    Year: 2023
    Citations: 1 📄